Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)

46.50
Delayed Data
As of Jul 02
 -1.75 / -3.63%
Today’s Change
8.49
Today|||52-Week Range
62.97
+327.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$905.7M

Company Description

Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Contact Information

Arcturus Therapeutics Holdings, Inc.
10628 Science Center Drive
San Diego California 92121
P:(858) 900-2660
Investor Relations:

Employees

Shareholders

Other institutional9.68%
Mutual fund holders17.87%
Individual stakeholders12.73%

Top Executives

There are no executives to display.